Trial Outcomes & Findings for Rural Interventions for Screening Effectiveness (NCT NCT02795104)
NCT ID: NCT02795104
Last Updated: 2023-10-02
Results Overview
Will be tested initially with pair-wise chi-square tests. Binary logistic regression analysis will be used to compare the two interventions and the UC group on the binary dependent variable (adherence), while adjusting for any potentially confounding covariates. The models will be controlled for any demographic covariate (e.g., age, education) for which the randomized groups differ significantly at baseline using a liberal significance level of 0.20 to achieve conservative adjustment. As a sensitivity analysis, multiple imputation will be used to impute the adherence outcome for participants.
COMPLETED
NA
985 participants
Up to 12 months
2023-10-02
Participant Flow
Participant milestones
| Measure |
Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)
TIDVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
|
Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)
TIDVD,PN: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
Arm III Usual Care (UC)
UC: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
|
|---|---|---|---|
|
Overall Study
STARTED
|
389
|
395
|
201
|
|
Overall Study
COMPLETED
|
382
|
388
|
193
|
|
Overall Study
NOT COMPLETED
|
7
|
7
|
8
|
Reasons for withdrawal
| Measure |
Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)
TIDVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
|
Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)
TIDVD,PN: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
Arm III Usual Care (UC)
UC: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
|
|---|---|---|---|
|
Overall Study
Determined to be Ineligible with Exit Data
|
7
|
5
|
7
|
|
Overall Study
Withdrawal by Subject
|
0
|
2
|
0
|
|
Overall Study
Lost to Follow-up
|
0
|
0
|
1
|
Baseline Characteristics
Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
Baseline characteristics by cohort
| Measure |
ARM I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
|
ARM II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator.
Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
ARM III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Educational Intervention via brochure: Educational Intervention via brochure:
In this arm of the educational intervention the participant receives brochures
|
Total
n=963 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Customized
Age at consent
|
58.2 years
STANDARD_DEVIATION 6.4 • n=5 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
|
58.8 years
STANDARD_DEVIATION 6.3 • n=7 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
|
58.8 years
STANDARD_DEVIATION 6.3 • n=5 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
|
58.6 years
STANDARD_DEVIATION 6.3 • n=4 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
|
|
Sex/Gender, Customized
Female
|
382 Participants
n=5 Participants
|
388 Participants
n=7 Participants
|
193 Participants
n=5 Participants
|
963 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
376 Participants
n=5 Participants
|
375 Participants
n=7 Participants
|
185 Participants
n=5 Participants
|
936 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
12 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Region of Enrollment
United States · Indiana
|
159 Participants
n=5 Participants
|
149 Participants
n=7 Participants
|
70 Participants
n=5 Participants
|
378 Participants
n=4 Participants
|
|
Region of Enrollment
United States · Ohio
|
223 Participants
n=5 Participants
|
239 Participants
n=7 Participants
|
123 Participants
n=5 Participants
|
585 Participants
n=4 Participants
|
PRIMARY outcome
Timeframe: Up to 12 monthsWill be tested initially with pair-wise chi-square tests. Binary logistic regression analysis will be used to compare the two interventions and the UC group on the binary dependent variable (adherence), while adjusting for any potentially confounding covariates. The models will be controlled for any demographic covariate (e.g., age, education) for which the randomized groups differ significantly at baseline using a liberal significance level of 0.20 to achieve conservative adjustment. As a sensitivity analysis, multiple imputation will be used to impute the adherence outcome for participants.
Outcome measures
| Measure |
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
|
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator.
Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Educational Intervention via brochure: Educational Intervention via brochure:
In this arm of the educational intervention the participant receives brochures
|
|---|---|---|---|
|
Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms
Received All Needed Screenings within 12-months of Enrollment
|
57 Participants
|
118 Participants
|
19 Participants
|
|
Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms
Received Any Needed Screening within 12-months of Enrollment
|
110 Participants
|
189 Participants
|
48 Participants
|
SECONDARY outcome
Timeframe: Up to 12 monthsPopulation: Same as main outcome. All participants included.
Cost-effectiveness analysis (CEA) implies a comparison of whether the cost per unit of outcome in one situation exceeds that in another. Unless the outcome measures are comparable, this is not possible. Will be able to examine outcomes of the interventions and the UC group (participants who up to date with all three cancer screening guidelines at 12 month follow-up). CEA will consist of measuring the incremental cost of achieving the observed incremental outcomes, but not a cost-effectiveness ratio in standard terms.
Outcome measures
| Measure |
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
|
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator.
Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Educational Intervention via brochure: Educational Intervention via brochure:
In this arm of the educational intervention the participant receives brochures
|
|---|---|---|---|
|
Cost Effectiveness of Each Intervention
|
14,462.64 USD ('22) per completed UTD screening
|
10,638.20 USD ('22) per completed UTD screening
|
0 USD ('22) per completed UTD screening
|
SECONDARY outcome
Timeframe: Up to 12 monthsPopulation: Same as main outcome. All participants of study.
In the model implemented in this study, the patient navigators spend full time in that activity. Thus, the costs of implementation are straightforward and obtainable. Even though the navigator is full-time, data were collected concerning broad categories of time use through a structured time log so that the cost of specific components (e.g., arranging transportation) can be estimated more accurately. A developed Participant Encounter Form and a Tracking Log of Direct Participant Contacts were used to provide the majority of this information.
Outcome measures
| Measure |
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
|
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator.
Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Educational Intervention via brochure: Educational Intervention via brochure:
In this arm of the educational intervention the participant receives brochures
|
|---|---|---|---|
|
Cost of the Interventions
|
326,012.29 US Dollars (2022)
|
670,841.46 US Dollars (2022)
|
0 US Dollars (2022)
|
Adverse Events
Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)
Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)
Arm III Usual Care (UC)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Ryan Baltic
The Ohio State University Comprehensive Cancer Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place